netFormulary Portsmouth and South East Hampshire NHS
Prescribing Formulary  
 Search
 Formulary Chapter 13: Skin - Full Chapter
Chapter Links...
 Details...
13.05.03  Expand sub section  Drugs affecting the immune response
Adalimumab injection (Imraldi Amgevita Humira)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
 
Link  NICE TA 455 Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people
Link  NICE TA146 Adalimumab for the treatment of adults with psoriasis
Link  NICE TA392: Adalimumab for treating moderate to severe hidradenitis suppurativa
   
Apremilast (Otezla)
(Tablets)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
 
Link  NICE TA 433 Apremilast for treating active psoriatic arthritis
Link  NICE TA419 Apremilast for treating moderate to severe plaque psoriasis
   
Cytotoxic Drug Azathioprine tablets
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber with Shared Care

unlicensedunlicensed

 
Link  Shared care guidelines Immune modulating therapies June 2019
   
BrodalumabBlack Triangle (Kyntheum)
(Subcutaneous injection)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
CCG
Homecare
 
Link  NICE TA 511 Brodalumab for treating moderate to severe plaque psoriasis
   
Ciclosporin  (Vanquoral)
(capsules)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber with Shared Care
 
Link  Shared care guidelines Immune modulating therapies June 2019
   
Dimethyl fumarate (Skilarence )
(tablets)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber with Shared Care
 
Link  Dimethyl fumerate shared care guideline 2018
Link  NICE TA 475 Dimethyl fumarate for treating moderate to severe plaque psoriasis
   
Dupilumab (Dupixent)
(Pre-filled syringe)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
CCG

NICE TA 534: Dupilumab for treating moderate to severe atopic dermatitis

 
   
Etanercept (biosimilar) injection (Benepali)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
Prescribe by brand name 
Link  NICE TA 103 Etanercept and efalizumab for the treatment of adults with psoriasis
Link  NICE TA 455 Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people
   
Etanercept injection (Enbrel)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine

Prescribe by brand name

 
Link  NICE TA 455 Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people
Link  NICE TA103: Psoriasis - efalizumab and etanercept
   
Guselkumab (Tremfya)
(Soultion for injection)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
 
Link  NICE TA 521: Guselkumab for treating moderate to severe plaque psoriasis
   
Infliximab (biosimilar) for infusion (Inflectra)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

Prescribe by brand name

 
Link  NICE TA 134 Infliximab for the treatment of adults with psoriasis
   
Infliximab (biosimilar) for infusion (Remsima)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

Prescribe by brand name

 
Link  NICE TA 134 Infliximab for the treatment of adults with psoriasis
   
Infliximab for infusion (Remicade)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
 
Link  NICE TA134: Infliximab for psoriasis
   
Ixekizumab injection (Taltz )
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
 
Link  NICE TA 442 Ixekizumab for treating moderate to severe plaque psoriasis
Link  NICE TA 537: Ixekizumab for treating active psoriatic arthritis after inadequate response to DMARDs
   
Cytotoxic Drug Methotrexate
(tablets, injection)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber with Shared Care

Tablets 2.5mg


Nordimet   - prefilled pen


Metoject PEN - prefilled pen

 
Link  Shared care guidelines Immune modulating therapies June 2019
   
Pimecrolimus 1% cream (Elidel)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber Recommended

Second line after topical steroids for moderate atopic eczema, especially face and neck - NICE TA 82. Not for children under 2 years

 
Link  NICE TA82: Pimecrolimus and tacrolimus for atopic dermatitis (eczema)
   
Risankizumab (Skyrizi)
(Pre-filled syringe)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
CCG
 
Link  NICE TA596: Risankizumab for treating moderate to severe plaque psoriasis
   
Secukinumab injection (Cosentyx)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
 
Link  NICE TA350: Plaque Psoriasis
Link  NICE TA407: Secukinumab for active ankylosing spondylitis after treatment with non-steroidal anti-inflammatory drugs or TNF-alpha inhibitors
   
Tacrolimus (Protopic)
(Ointment)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber Recommended

0.03% and 0.1%

 

Second-line after steroids for moderate to severe atopic eczema - NICE TA 82. Not for children under 2. Age 2-16 use 0.03% only

 
Link  NICE TA82: Pimecrolimus and tacrolimus for atopic dermatitis (eczema)
   
Tildrakizumab (Ilumetri)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
 
Link  NICE TA575 Tildrakizumab for treating moderate to severe plaque psoriasis
   
Ustekinumab injection (Stelara)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
 
Link  NICE TA 455 Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people
Link  NICE TA180: Psoriasis - ustekinumab
Link  NICE TA340: Ustekinumab for treating active psoriatic arthritis
   
 ....
 Non Formulary Items
Efalizumab  (Raptiva)

View adult BNF View SPC online View childrens BNF Track Changes
Non Formulary

This drug has been withdrawn

 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Green

Primary and Secondary Care (unrestricted) may be prescribed by GPs, hospital doctors or other qualified prescribers in primary and secondary care  

Amber Initiation

Amber Initiated: first prescription from specialist, on going supplies from primary care (or when stabilised on therapy).  

Amber Recommended

Amber recommended: first prescription may be supplied by primary care under the advice of a specialist.  

Amber with Shared Care

For initiation within a specialist service followed by ongoing prescribing in primary care according to published shared care guidance  

Red

For initiation and ongoing prescribing in secondary care only. Medicines in this category may be further restricted to use by specific hospital departments only.  

Blue

For prescribing in primary care only  

netFormulary